IBM

International Business Machines Corporation

65
Fundamentals71/ 100
Valuation57/ 100
Upside potential62/ 100
Risk potential15/ 100

IBM has the edge over LCID overall, supported by lower modeled downside and stronger valuation.

LCID

Lucid Group, Inc.

52
Fundamentals65/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

LCID's outlook is improving, though it still trails on the overall score.

IBM Fundamentals

MetricStatus
Stable
Strong
Strong
Under pressure

IBM's profitability and cash flow are currently strong, and its revenue is stable, but its balance sheet is under pressure.

LCID Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

IBM PE Valuation

CHEAPFAIREXPENSIVE28x56x85x113x
CHEAPFAIREXPENSIVE28x56x85x113x
LevelPEPriceVs current
Cheap17x$194-21%
Forward19x$245—
Current21x$245—
Fair23x$274+12%
Expensive46x$538+120%

Historical ranges are pointers, not guarantees.

IBM's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.

LCID PE Valuation

LCID has no meaningful PE right now: it lost money over the past year.

IBM Forward outlook

MetricOutlook
Improving
Growth
Stable
Improving
Moderate
Moderate

Analysts expect IBM's earnings to grow and its profitability to improve, with its revenue holding steady.

LCID Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
Low

Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

IBM Risk to reward

ScenarioChangePrice
Upside+26%$307.43
Downside-15%$206.85

Calculated from the latest close: $244.67 on Nov 12.

IBM trails LCID on modeled risk to reward, with less potential upside relative to its potential downside.

LCID Risk to reward

ScenarioChangePrice
Upside+63%$5.30
Downside-38%$2.02

Calculated from the latest close: $3.25 on Nov 12.

LCID has a better modeled risk to reward balance than IBM, with more potential upside relative to its potential downside.

IBM Earnings Per Share

Q4 2023: $8.14Q1 2024: $8.85Q2 2024: $9.09Q3 2024: $6.89Q4 2024: $6.43Q1 2025: $5.83Q2 2025: $6.18Q3 2025: $8.38Q4 2025: $11.17Q1 2026: $11.33Q2 2026: $11.29Q3 2026: $11.75Forward: $13.06
Q4 2023: $8.14Q1 2024: $8.85Q2 2024: $9.09Q3 2024: $6.89Q4 2024: $6.43Q1 2025: $5.83Q2 2025: $6.18Q3 2025: $8.38Q4 2025: $11.17Q1 2026: $11.33Q2 2026: $11.29Q3 2026: $11.75Forward: $13.06
QuarterTTM EPSYoY
Forward$13.06+11%
Q3 2026$11.75+40%
Q2 2026$11.29+83%
Q1 2026$11.33+94%
Q4 2025$11.17+74%
Q3 2025$8.38+22%
Q2 2025$6.18-32%
Q1 2025$5.83-34%
Q4 2024$6.43-21%

IBM has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.

LCID Earnings Per Share

Q4 2023: $-13.60Q1 2024: $-12.30Q2 2024: $-11.70Q3 2024: $-13.00Q4 2024: $-12.50Q1 2025: $-11.90Q2 2025: $-11.30Q3 2025: $-10.51Q4 2025: $-12.09Q1 2026: $-13.15Q2 2026: $-13.65Q3 2026: $-13.08
Q4 2023: $-13.60Q1 2024: $-12.30Q2 2024: $-11.70Q3 2024: $-13.00Q4 2024: $-12.50Q1 2025: $-11.90Q2 2025: $-11.30Q3 2025: $-10.51Q4 2025: $-12.09Q1 2026: $-13.15Q2 2026: $-13.65Q3 2026: $-13.08
QuarterTTM EPSYoY
Q3 2026-$13.08-$2.57
Q2 2026-$13.65-$2.35
Q1 2026-$13.15-$1.25
Q4 2025-$12.09+$0.41
Q3 2025-$10.51+$2.49
Q2 2025-$11.30+$0.40
Q1 2025-$11.90+$0.40
Q4 2024-$12.50+$1.10

LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.

IBM Quarterly Revenue

Q4 2023: $17.4BQ1 2024: $14.5BQ2 2024: $15.8BQ3 2024: $15BQ4 2024: $17.6BQ1 2025: $14.5BQ2 2025: $17BQ3 2025: $16.3BQ4 2025: $19.7BQ1 2026: $15.9BQ2 2026: $17.2BQ3 2026: $17.1B
Q4 2023: $17.4BQ1 2024: $14.5BQ2 2024: $15.8BQ3 2024: $15BQ4 2024: $17.6BQ1 2025: $14.5BQ2 2025: $17BQ3 2025: $16.3BQ4 2025: $19.7BQ1 2026: $15.9BQ2 2026: $17.2BQ3 2026: $17.1B
QuarterRevenueYoY
Q3 2026$17.1B+4.7%
Q2 2026$17.2B+1.1%
Q1 2026$15.9B+9.5%
Q4 2025$19.7B+12%
Q3 2025$16.3B+9.1%
Q2 2025$17B+7.7%
Q1 2025$14.5B+0.5%
Q4 2024$17.6B+1%

IBM's revenue has grown year over year for 13 quarters in a row: $17.1B last quarter, up 4.7% from the same quarter a year ago.

LCID Quarterly Revenue

Q4 2023: $157MQ1 2024: $173MQ2 2024: $201MQ3 2024: $200MQ4 2024: $234MQ1 2025: $235MQ2 2025: $259MQ3 2025: $337MQ4 2025: $523MQ1 2026: $282MQ2 2026: $405MQ3 2026: $350M
Q4 2023: $157MQ1 2024: $173MQ2 2024: $201MQ3 2024: $200MQ4 2024: $234MQ1 2025: $235MQ2 2025: $259MQ3 2025: $337MQ4 2025: $523MQ1 2026: $282MQ2 2026: $405MQ3 2026: $350M
QuarterRevenueYoY
Q3 2026$350.3M+4.1%
Q2 2026$405.3M+56%
Q1 2026$282.5M+20%
Q4 2025$522.7M+123%
Q3 2025$336.6M+68%
Q2 2025$259.4M+29%
Q1 2025$235M+36%
Q4 2024$234.5M+49%

LCID has the edge over IBM on sales, with stronger typical year-over-year growth.

IBM Free Cash Flow

Q4 2023: $4.2BQ1 2024: $3.9BQ2 2024: $1.8BQ3 2024: $2.6BQ4 2024: $4BQ1 2025: $4.1BQ2 2025: $1.5BQ3 2025: $2.8BQ4 2025: $3.7BQ1 2026: $4.9BQ2 2026: $2.4BQ3 2026: $3.7B
Q4 2023: $4.2BQ1 2024: $3.9BQ2 2024: $1.8BQ3 2024: $2.6BQ4 2024: $4BQ1 2025: $4.1BQ2 2025: $1.5BQ3 2025: $2.8BQ4 2025: $3.7BQ1 2026: $4.9BQ2 2026: $2.4BQ3 2026: $3.7B
QuarterFree cash flowYoY
Q3 2026$3.7B+31%
Q2 2026$2.4B+59%
Q1 2026$4.9B+20%
Q4 2025$3.7B-9.2%
Q3 2025$2.8B+8.9%
Q2 2025$1.5B-19%
Q1 2025$4.1B+5%
Q4 2024$4B-3.3%

IBM has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.

LCID Free Cash Flow

Q4 2023: −$747MQ1 2024: −$715MQ2 2024: −$741MQ3 2024: −$622MQ4 2024: −$825MQ1 2025: −$590MQ2 2025: −$1BQ3 2025: −$955MQ4 2025: −$1.2BQ1 2026: −$1.4BQ2 2026: −$1.5BQ3 2026: −$1B
Q4 2023: −$747MQ1 2024: −$715MQ2 2024: −$741MQ3 2024: −$622MQ4 2024: −$825MQ1 2025: −$590MQ2 2025: −$1BQ3 2025: −$955MQ4 2025: −$1.2BQ1 2026: −$1.4BQ2 2026: −$1.5BQ3 2026: −$1B
QuarterFree cash flowYoY
Q3 2026-$1B-$84.2M
Q2 2026-$1.5B-$463.2M
Q1 2026-$1.4B-$849M
Q4 2025-$1.2B-$417.1M
Q3 2025-$955.5M-$333M
Q2 2025-$1B-$271.6M
Q1 2025-$589.9M+$125.1M
Q4 2024-$824.8M-$77.6M

LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.

IBM Total Shares

Q4 2023: 922MQ1 2024: 933MQ2 2024: 934MQ3 2024: 924MQ4 2024: 937MQ1 2025: 945MQ2 2025: 948MQ3 2025: 949MQ4 2025: 949MQ1 2026: 952MQ2 2026: 953MQ3 2026: 954M
Q4 2023: 922MQ1 2024: 933MQ2 2024: 934MQ3 2024: 924MQ4 2024: 937MQ1 2025: 945MQ2 2025: 948MQ3 2025: 949MQ4 2025: 949MQ1 2026: 952MQ2 2026: 953MQ3 2026: 954M
PeriodChange %Net change
Quarterly0%+260K shares
1 year+0.5%+4.6M shares
3 years+3.2%+29.9M shares
5 years+5.3%+47.6M shares
Available history+2.1%+19.6M shares

IBM has the edge over LCID on shareholder dilution, with a more favorable share count trend.

LCID Total Shares

Q4 2023: 208MQ1 2024: 230MQ2 2024: 231MQ3 2024: 232MQ4 2024: 245MQ1 2025: 304MQ2 2025: 306MQ3 2025: 312MQ4 2025: 313MQ1 2026: 328MQ2 2026: 382MQ3 2026: 395M
Q4 2023: 208MQ1 2024: 230MQ2 2024: 231MQ3 2024: 232MQ4 2024: 245MQ1 2025: 304MQ2 2025: 306MQ3 2025: 312MQ4 2025: 313MQ1 2026: 328MQ2 2026: 382MQ3 2026: 395M
PeriodChange %Net change
Quarterly+3.3%+12.5M shares
1 year+26%+82.4M shares
3 years+73%+166M shares

LCID has 395M diluted shares, up 26% from a year ago.

IBM Net Leverage

Q4 2023: 3.8xQ1 2024: 3.8xQ2 2024: 3.6xQ3 2024: 4.3xQ4 2024: 4.4xQ1 2025: 5.6xQ2 2025: 5.5xQ3 2025: 4.2xQ4 2025: 3.5xQ1 2026: 4.0xQ2 2026: 3.9xQ3 2026: 3.9x
Q4 2023: 3.8xQ1 2024: 3.8xQ2 2024: 3.6xQ3 2024: 4.3xQ4 2024: 4.4xQ1 2025: 5.6xQ2 2025: 5.5xQ3 2025: 4.2xQ4 2025: 3.5xQ1 2026: 4.0xQ2 2026: 3.9xQ3 2026: 3.9x
QuarterNet LeverageStatus
Q3 20263.9xElevated
Q2 20263.9xElevated
Q1 20264.0xHigh
Q4 20253.5xElevated
Q3 20254.2xHigh
Q2 20255.5xHigh
Q1 20255.6xHigh
Q4 20244.4xHigh

IBM's net debt is about 3.9 years of its operating earnings (EBITDA), down from 4.2 years a year ago.

LCID Net Leverage

LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

IBM Weekly Momentum

MetricValueStatus
RSI50.1Neutral
Stochastic74.8Neutral

IBM's weekly RSI is 50 (neutral) and its Stochastic is 75 (neutral).

LCID Weekly Momentum

MetricValueStatus
RSI32.9Neutral
Stochastic7.1Oversold

LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

IBM PE vs Technology Sector

MetricIBMSector medianRelative
PE21x28x25% below
PE %31354 pts below

IBM is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.

LCID PE vs Consumer Cyclical Sector

LCID has no meaningful PE right now: it lost money over the past year.

IBM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$238.62.6% above
20 week MA$239.32.2% above
50 week MA$256.64.6% below
100 week MA$258.55.3% below
200 week MA$212.315% above

IBM has the edge over LCID on trend strength, trading above more of its moving averages.

LCID Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.537.9% below
20 week MA$4.8833% below
50 week MA$7.3356% below
100 week MA$15.479% below
200 week MA$31.990% below

LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.

IBM Yearly ROI

YearStart priceEnd priceROI
2020$129.3$119.2-7.8%
2021$119.2$130.6+9.6%
2022$130.6$141.7+8.4%
2023$141.7$163.6+15%
2024$163.6$222.8+36%
2025$222.8$305.1+37%
2026 YTD$305.1$244.7-20%

IBM has the edge over LCID on returns for 2026, with the stronger performance.

LCID Yearly ROI

YearStart priceEnd priceROI
2020$98.9$100.4+1.5%
2021$100.4$376.4+275%
2022$376.4$67.0-82%
2023$67.0$42.1-37%
2024$42.1$32.0-24%
2025$32.0$11.4-64%
2026 YTD$11.4$3.25-72%

LCID has finished four years in a row lower, and it's down 72% so far in 2026.

Give your agent the market.

Get API key